Alteryx Inc (AYX)

US02156B1035 - Common Stock

48.26  +0.01 (+0.02%)

After market: 48.28 +0.02 (+0.04%)

Fundamental Rating

3

Overall AYX gets a fundamental rating of 3 out of 10. We evaluated AYX against 276 industry peers in the Software industry. Both the profitability and financial health of AYX have multiple concerns. AYX is valued quite expensive, but it does show an excellent growth.



2

1. Profitability

1.1 Basic Checks

AYX had positive earnings in the past year.
In the past year AYX had a positive cash flow from operations.
In the past 5 years AYX reported 4 times negative net income.
Of the past 5 years AYX 4 years had a positive operating cash flow.

1.2 Ratios

The Return On Assets of AYX (-9.36%) is comparable to the rest of the industry.
AYX's Return On Equity of -94.21% is on the low side compared to the rest of the industry. AYX is outperformed by 74.10% of its industry peers.
Industry RankSector Rank
ROA -9.36%
ROE -94.21%
ROIC N/A
ROA(3y)-13.68%
ROA(5y)-8.14%
ROE(3y)-107.39%
ROE(5y)-64.18%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

The Gross Margin of AYX (86.44%) is better than 93.88% of its industry peers.
AYX's Gross Margin has been stable in the last couple of years.
The Profit Margin and Operating Margin are not available for AYX so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 86.44%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.73%
GM growth 5Y-1.01%

2

2. Health

2.1 Basic Checks

AYX does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for AYX has been increased compared to 1 year ago.
AYX has more shares outstanding than it did 5 years ago.
AYX has a worse debt/assets ratio than last year.

2.2 Solvency

AYX has an Altman-Z score of 1.24. This is a bad value and indicates that AYX is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of AYX (1.24) is worse than 60.07% of its industry peers.
The Debt to FCF ratio of AYX is 47.62, which is on the high side as it means it would take AYX, 47.62 years of fcf income to pay off all of its debts.
AYX's Debt to FCF ratio of 47.62 is in line compared to the rest of the industry. AYX outperforms 47.48% of its industry peers.
A Debt/Equity ratio of 4.42 is on the high side and indicates that AYX has dependencies on debt financing.
The Debt to Equity ratio of AYX (4.42) is worse than 86.33% of its industry peers.
Industry RankSector Rank
Debt/Equity 4.42
Debt/FCF 47.62
Altman-Z 1.24
ROIC/WACCN/A
WACC8.56%

2.3 Liquidity

A Current Ratio of 1.45 indicates that AYX should not have too much problems paying its short term obligations.
The Current ratio of AYX (1.45) is comparable to the rest of the industry.
AYX has a Quick Ratio of 1.45. This is a normal value and indicates that AYX is financially healthy and should not expect problems in meeting its short term obligations.
AYX has a Quick ratio (1.45) which is in line with its industry peers.
Industry RankSector Rank
Current Ratio 1.45
Quick Ratio 1.45

8

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 2142.86% over the past year.
Measured over the past years, AYX shows a quite strong growth in Earnings Per Share. The EPS has been growing by 15.42% on average per year.
The Revenue has grown by 13.42% in the past year. This is quite good.
AYX shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 30.77% yearly.
EPS 1Y (TTM)2142.86%
EPS 3Y15.42%
EPS 5YN/A
EPS growth Q2Q102.38%
Revenue 1Y (TTM)13.42%
Revenue growth 3Y25.11%
Revenue growth 5Y30.77%
Revenue growth Q2Q16.57%

3.2 Future

AYX is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 19.64% yearly.
The Revenue is expected to grow by 17.39% on average over the next years. This is quite good.
EPS Next Y-10.23%
EPS Next 2Y8.99%
EPS Next 3Y6.08%
EPS Next 5Y19.64%
Revenue Next Year12.19%
Revenue Next 2Y12.05%
Revenue Next 3Y19.72%
Revenue Next 5Y17.39%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.

2

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 33.75, AYX can be considered very expensive at the moment.
AYX's Price/Earnings ratio is a bit cheaper when compared to the industry. AYX is cheaper than 76.62% of the companies in the same industry.
When comparing the Price/Earnings ratio of AYX to the average of the S&P500 Index (24.92), we can say AYX is valued slightly more expensively.
The Price/Forward Earnings ratio is 37.59, which means the current valuation is very expensive for AYX.
Based on the Price/Forward Earnings ratio, AYX is valued a bit cheaper than the industry average as 65.11% of the companies are valued more expensively.
AYX is valuated expensively when we compare the Price/Forward Earnings ratio to 21.49, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 33.75
Fwd PE 37.59

4.2 Price Multiples

AYX's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 134.14
EV/EBITDA N/A

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y8.99%
EPS Next 3Y6.08%

0

5. Dividend

5.1 Amount

No dividends for AYX!.
Industry RankSector Rank
Dividend Yield N/A

Alteryx Inc

NYSE:AYX (3/18/2024, 8:04:00 PM)

After market: 48.28 +0.02 (+0.04%)

48.26

+0.01 (+0.02%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap3.49B
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 33.75
Fwd PE 37.59
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -9.36%
ROE -94.21%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 86.44%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.51
Health
Industry RankSector Rank
Debt/Equity 4.42
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 1.45
Quick Ratio 1.45
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)2142.86%
EPS 3Y15.42%
EPS 5Y
EPS growth Q2Q
EPS Next Y-10.23%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)13.42%
Revenue growth 3Y25.11%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y